Shares of Owens & Minor (OMI) plummeted 5.28% in Thursday's trading session following the release of its first-quarter 2025 financial results. The medical supplies company reported mixed results, with revenue falling short of expectations while adjusted earnings per share beat estimates.
Owens & Minor reported Q1 revenue of $2.632 billion, missing analysts' expectations of $2.658 billion. The company also posted a net loss of $25 million for the quarter, contributing to the negative market reaction. Despite these challenges, adjusted earnings per share came in at $0.23, surpassing the estimated $0.20.
The company provided its full-year outlook, projecting adjusted EPS between $1.60 and $1.85, and revenue in the range of $10.85 billion to $11.15 billion. Additionally, Owens & Minor stated that it remains "actively engaged in the potential sale of Products & Healthcare Services Segment," which may be influencing investor sentiment. The market's response suggests concerns about the company's overall financial health and future prospects, despite some positive elements in the earnings report.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.